Get the Stockscreener App
29.71
3.07%
-0.94
Guardian Pharmacy Services Inc stock is traded at $29.71, with a volume of 270.73K.
It is down -3.07% in the last 24 hours and down -3.35% over the past month.
Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.
See More
Previous Close:
$30.65
Open:
$30.34
24h Volume:
270.73K
Relative Volume:
0.87
Market Cap:
$1.88B
Revenue:
$1.33B
Net Income/Loss:
$-75.88M
P/E Ratio:
-20.07
EPS:
-1.48
Net Cash Flow:
$37.92M
1W Performance:
+4.91%
1M Performance:
-3.35%
6M Performance:
+44.57%
1Y Performance:
+37.67%
1-Day Range:
$29.07
$30.56
1-Week Range:
$27.53
$31.11
52-Week Range:
$17.78
$37.43
Guardian Pharmacy Services Inc Stock (GRDN) Company Profile
Name
Guardian Pharmacy Services Inc
Sector
Industry
Phone
(404) 810-0089
Address
300 GALLERIA PARKWAY SE, ATLANTA
Compare GRDN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GRDN
Guardian Pharmacy Services Inc
|
29.71 | 1.94B | 1.33B | -75.88M | 37.92M | -1.48 |
|
HCA
Hca Healthcare Inc
|
505.84 | 107.79B | 74.37B | 7.31B | 8.10B | 25.88 |
|
THC
Tenet Healthcare Corp
|
189.15 | 16.69B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
22.42 | 12.86B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
UHS
Universal Health Services Inc
|
202.64 | 12.88B | 16.08B | 1.20B | 1.06B | 17.82 |
|
ENSG
Ensign Group Inc
|
171.99 | 10.32B | 4.11B | 239.98M | 193.10M | 4.12 |
Guardian Pharmacy Services Inc Stock (GRDN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-10-25 | Initiated | Oppenheimer | Outperform |
| Oct-21-24 | Initiated | Raymond James | Outperform |
| Oct-21-24 | Initiated | Truist | Buy |
Guardian Pharmacy Services Inc Stock (GRDN) Latest News
Rakuten Investment Management Inc. Takes Position in Guardian Pharmacy Services, Inc. $GRDN - Defense World
Guardian Pharmacy Services’ (GRDN) Flat 2026 Revenue Guide: Pragmatic Planning or Fading Growth Ambition? - simplywall.st
Stephens Is Bullish on Guardian Pharmacy Services, Inc. (GRDN) After 2026 Forecast Update - Finviz
Stephens is bullish on Guardian Pharmacy Services, Inc. (GRDN) after 2026 forecast update - MSN
12 Cheap Small-Cap Stocks to Invest In Before the Next Breakout - Insider Monkey
Bear Alert: Whats the profit margin of Guardian Pharmacy Services IncJuly 2025 Reactions & Verified Entry Point Detection - baoquankhu1.vn
Guardian Pharmacy Services : Right Dose Pharmacy Opens New Ankeny, Iowa Headquarters to Meet Growing Demand for Long-Term Care Pharmacy Services - marketscreener.com
Guardian Pharmacy Services (NYSE:GRDN) Shares Down 6.9%Time to Sell? - MarketBeat
Guardian Pharmacy Services : Participates in J.P. Morgan Healthcare Conference - marketscreener.com
Growth Report: Is Guardian Pharmacy Services Inc stock undervalued right nowDip Buying & Free High Return Stock Watch Alerts - baoquankhu1.vn
Is Dolby Laboratories Inc forming a breakout patternQuarterly Growth Report & Safe Entry Momentum Tips - baoquankhu1.vn
Guardian Pharmacy Services, Inc. (NYSE:GRDN) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Guardian Pharmacy Services stock price target raised to $36 at Stephens - Investing.com Nigeria
Guardian pharmacy services forecasts continued double-digit EBITDA growth By Investing.com - Investing.com Nigeria
Guardian Pharmacy Reaffirms 2025 Outlook, Issues 2026 Guidance - TipRanks
Guardian pharmacy services forecasts continued double-digit EBITDA growth - Investing.com
Guardian Pharmacy Services Reiterates 2025 Guidance and Provides 2026 Outlook - marketscreener.com
Despite drug price cuts, Guardian Pharmacy sees 2026 EBITDA growth - Stock Titan
With 35% ownership, Guardian Pharmacy Services, Inc. (NYSE:GRDN) has piqued the interest of institutional investors - Yahoo Finance
Winners Losers: How sustainable is Guardian Pharmacy Services Inc. stock dividend payoutMarket Movement Recap & Capital Efficiency Focused Ideas - Улправда
Guardian Pharmacy Services, Inc. Class A Common Stock (NY: GRDN - FinancialContent
Can Guardian Pharmacy Services Inc. stock outperform in 2025 bull marketJuly 2025 Rallies & Low Drawdown Trading Techniques - ulpravda.ru
How sustainable is Guardian Pharmacy Services Inc. stock dividend payoutPortfolio Performance Report & AI Driven Stock Movement Reports - Улправда
Published on: 2026-01-09 01:23:30 - ulpravda.ru
The Bull Case For Guardian Pharmacy Services (GRDN) Could Change Following Surge In High‑Volatility Call Options – Learn Why - simplywall.st
Allspring Global Investments Holdings LLC Sells 80,930 Shares of Guardian Pharmacy Services, Inc. $GRDN - Defense World
Implied Volatility Surging for Guardian Pharmacy Services Stock Options - TradingView
Analysts Offer Insights on Healthcare Companies: Agilent (A) and Tenet Healthcare (THC) - The Globe and Mail
Investor Optimism Abounds Guardian Pharmacy Services, Inc. (NYSE:GRDN) But Growth Is Lacking - 富途牛牛
Free cash flow per share of Guardian Pharmacy Services, Inc. – NYSE:GRDN - TradingView — Track All Markets
US Market Recap: What downside risks could hit Guardian Pharmacy Services Inc Class stockQuarterly Performance Summary & Weekly Momentum Stock Picks - moha.gov.vn
Guardian Pharmacy Services prices stock offering at $21 per share - MSN
Risk Analysis: What insider purchases suggest about abrdn Bloomberg All Commodity Strategy stockMarket Rally & Daily Entry Point Alerts - moha.gov.vn
GDL Leasing and Finance Limited Builds Base for Possible ReboundDay Trading Setups & Affordable Market Growth - bollywoodhelpline.com
B2B Software Technologies Limited Crosses 200 Day MA — Signal or NoiseTrendline Breakouts & Build Wealth With Strategy - bollywoodhelpline.com
Guardian Pharmacy Services (NYSE:GRDN) Trading Down 0.8% – Should You Sell? - Defense World
Guardian Pharmacy Services (NYSE:GRDN) Trading Down 0.8%Should You Sell? - MarketBeat
Is There Enough Volume to Lift N2N Technologies LimitedEconomic Indicators Overview & Small Capital Portfolio - bollywoodhelpline.com
Guardian Pharmacy Expands to Washington via Acquisition - MSN
Instrumental (Gujarat) Limited — Volatility AheadHigh Dividend Yield Stocks & Wealth Building Starts With One Click - bollywoodhelpline.com
Screener Results Flag Drone Destination Limited as OversoldUtilities Sector Analysis & Affordable Trading Strategies - bollywoodhelpline.com
Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Strong Revenue Growth and Analyst Confidence Signal Promising Upside - DirectorsTalk Interviews
Do Its Financials Have Any Role To Play In Driving Guardian Pharmacy Services, Inc.'s (NYSE:GRDN) Stock Up Recently? - Yahoo Finance
Did Guardian’s Shift Into the S&P Health Care Services Index (GRDN) Just Reframe Its Core Business? - simplywall.st
Guardian Pharmacy Services, Inc.(NYSE:GRDN) added to S&P Health Care Services Select Industry Index - marketscreener.com
Guardian Pharmacy Services, Inc.(NYSE:GRDN) dropped from S&P Retail Select Industry Index - marketscreener.com
Is Guardian Pharmacy Services Inc. stock supported by strong cash flowsJuly 2025 Chart Watch & Detailed Earnings Play Alerts - Улправда
Dow Update: How Guardian Pharmacy Services Inc stock compares to market leadersTrade Risk Assessment & Weekly High Return Forecasts - Bộ Nội Vụ
Is Guardian Pharmacy Services Inc. stock a buy before product launchesPortfolio Gains Summary & Verified Chart Pattern Trade Signals - Улправда
Guardian Pharmacy Services Inc Stock (GRDN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):